Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.32% | 72.11 | 0.9% | $619.68m | |
| CELG | Celgene Corporation | 0.06% | 127.65 | 1.1% | $445.33m | |
| AMGN | Amgen Inc. | -0.31% | 167.29 | 1.1% | $418.48m | |
| BIIB | Biogen Inc. | -0.93% | 281.77 | 1.2% | $356.38m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.85% | 467.98 | 2.7% | $321.83m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.28% | 148.13 | 1.9% | $264.60m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.91% | 133.40 | 1.9% | $217.97m | |
| ILMN | Illumina, Inc. | -0.98% | 189.32 | 3.5% | $216.35m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.46% | 36.70 | 19.8% | $138.44m | |
| INCY | Incyte Corporation | -0.45% | 121.19 | 2.6% | $130.95m | |
| CLVS | Clovis Oncology, Inc. | 2.99% | 71.96 | 18.0% | $129.20m | |
| KITE | Kite Pharma, Inc. | 3.29% | 130.18 | 16.1% | $121.84m | |
| TSRO | TESARO, Inc. | 4.41% | 113.86 | 14.7% | $121.68m | |
| A | Agilent Technologies, Inc. | 0.62% | 61.24 | 1.5% | $119.01m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.07% | 80.92 | 4.4% | $108.58m |
Company Profile
NewLink Genetics Corp. is a clinical stage immuno-oncology company, which focuses on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.